Skip to search.
 TSX Up 0.38% TSX Ventures Up 0.67%

Dyax Corp. (DYAX)

-NasdaqGM
22.04 Down 0.99(4.30%) Sep 3, 4:00PM EDT
|After Hours : 22.04 0.00 (0.00%) Sep 3, 4:34PM EDT
Add to Portfolio
Prev Close:23.03
Open:23.05
Bid:1.00 x 100
Ask:N/A
1y Target Est:29.63
Beta:1.04405
Earnings Date:Oct 26 - Oct 30 (Est.)
Day's Range:22.00 - 23.54
52wk Range:9.19 - 30.55
Volume:688,179
Avg Vol (3m):945,174
Market Cap:3.23B
P/E (ttm):N/A
EPS (ttm):-0.14
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
DYAXDown 4.30%3.23B
BCRXDown 3.05%815.15M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):35.55
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.28
Quarterly EPS Est (Sep-15) :-0.08
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-2.78

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dyax Corp., a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and other plasma-kallikrein-mediated (PKM) disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback